- Report
- October 2024
- 200 Pages
Global
From €3331EUR$3,750USD£2,890GBP
- Report
- October 2024
- 200 Pages
Global
From €3331EUR$3,750USD£2,890GBP
- Report
- December 2024
- 200 Pages
Global
From €3331EUR$3,750USD£2,890GBP
- Report
- December 2024
- 146 Pages
Global
From €2807EUR$3,160USD£2,435GBP
€3508EUR$3,950USD£3,044GBP
- Report
- March 2025
- 150 Pages
Global
From €3419EUR$3,850USD£2,967GBP
€4308EUR$4,850USD£3,738GBP
- Report
- March 2025
- 150 Pages
Global
From €3419EUR$3,850USD£2,967GBP
€4308EUR$4,850USD£3,738GBP
- Report
- June 2025
- 400 Pages
Global
From €4396EUR$4,949USD£3,814GBP
- Report
- July 2025
- 350 Pages
Global
From €4396EUR$4,949USD£3,814GBP
- Report
- July 2025
- 350 Pages
Global
From €4396EUR$4,949USD£3,814GBP
- Report
- October 2024
- 200 Pages
Global
From €4396EUR$4,949USD£3,814GBP
- Report
- January 2025
- 209 Pages
Global
From €4436EUR$4,995USD£3,850GBP
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,221USD£3,143GBP
- Report
- May 2025
- 92 Pages
Global
From €3500EUR$4,221USD£3,143GBP
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,221USD£3,143GBP
From €6661EUR$7,500USD£5,780GBP
- Report
- December 2024
- 436 Pages
Global
From €3553EUR$4,000USD£3,083GBP
- Report
- July 2025
- 132 Pages
Global
From €3662EUR$4,123USD£3,177GBP
€4308EUR$4,850USD£3,738GBP
- Report
- March 2025
- 142 Pages
Global
From €3662EUR$4,123USD£3,177GBP
€4308EUR$4,850USD£3,738GBP
- Report
- April 2025
- 120 Pages
United States
From €4352EUR$4,900USD£3,777GBP
- Report
- June 2025
- 250 Pages
United States
From €2477EUR$2,789USD£2,150GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more